Regulation of the calcium release channel from skeletal muscle by suramin and the disulfonated stilbene derivatives DIDS, DBDS, and DNDS

被引:33
作者
O'Neill, ER [1 ]
Sakowska, MM [1 ]
Laver, DR [1 ]
机构
[1] Univ Newcastle, Fac Hlth, Sch Biomed Sci, Callaghan, NSW 2308, Australia
基金
澳大利亚研究理事会;
关键词
D O I
10.1016/S0006-3495(03)74976-5
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Activation of skeletal muscle ryanodine receptors (RyRs) by suramin and disulfonic stilbene derivatives (Diisothiocyanostilbene-2',2'-disulfonic acid (DIDS), 4,4'-dibenzamidostilbene-2,2'-disulfonic acid (DBDS),and 4,4'-dinitrostilbene-2,2'-disulfonic acid (DNDS)) was investigated using planar bilayers. One reversible and two nonreversible mechanisms were identified. K-a for reversible activation (similar to100 muM) depended on cytoplasmic [Ca2+] and the bilayer composition. Replacement of neutral lipids by negative phosphatidylserine increased K-a fourfold, suggesting that reversible binding sites are near the bilayer surface. Suramin and the stilbene derivatives adsorbed to neutral bilayers with maximal mole fractions between 1-8% and with affinities similar to100 muM but did not adsorb to negative lipids. DIDS activated RyRs by two nonreversible mechanisms, distinguishable by their disparate DIDS binding rates (10(5) and 60 M-1 s(-1)) and actions. Both mechanisms activated RyRs via several jumps in open probability, indicating several DIDS binding events. The fast and slow mechanisms are independent of each other, the reversible mechanism and ATP binding. The fast mechanism confers DIDS sensitivity similar to1000-fold greater than previously reported, increases Ca2+ activation and increases K-i for Ca2+/Mg2+ inhibition 10-fold. The slow mechanism activates RyRs in the absence of Ca2+ and ATP, increases ATP activation without altering K-a, and slightly increases activity at pH < 6.5. These findings explain how different types of DIDS activation are observed under different conditions.
引用
收藏
页码:1674 / 1689
页数:16
相关论文
共 35 条
[1]   BOUND AND DETERMINED - A COMPUTER-PROGRAM FOR MAKING BUFFERS OF DEFINED ION CONCENTRATIONS [J].
BROOKS, SPJ ;
STOREY, KB .
ANALYTICAL BIOCHEMISTRY, 1992, 201 (01) :119-126
[2]  
CHU A, 1988, METHOD ENZYMOL, V157, P36
[3]   STRUCTURE AND FUNCTION OF RYANODINE RECEPTORS [J].
CORONADO, R ;
MORRISSETTE, J ;
SUKHAREVA, M ;
VAUGHAN, DM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :C1485-C1504
[4]   SURAMIN - A REVERSIBLE P2-PURINOCEPTOR ANTAGONIST IN THE MOUSE VASDEFERENS [J].
DUNN, PM ;
BLAKELEY, AGH .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) :243-245
[5]   THE ELECTRICAL DOUBLE LAYER AND THE THEORY OF ELECTROCAPILLARITY [J].
GRAHAME, DC .
CHEMICAL REVIEWS, 1947, 41 (03) :441-501
[6]   Molecular dissection, tissue localization and Ca2+ binding of the ryanodine receptor of Caenorhabditis elegans [J].
Hamada, T ;
Sakube, Y ;
Ahnn, J ;
Kim, DH ;
Kagawa, H .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 324 (01) :123-135
[7]   DIDS modifies the conductance, gating, and inactivation mechanisms of the cardiac ryanodine receptor [J].
Hill, AP ;
Sitsapesan, R .
BIOPHYSICAL JOURNAL, 2002, 82 (06) :3037-3047
[8]   Identification of 30 kDa protein for Ca2+ releasing action of myotoxin a with a mechanism common to DIDS in skeletal muscle sarcoplasmic reticulum [J].
Hirata, Y ;
Nakahata, N ;
Ohkura, M ;
Ohizumi, Y .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1451 (01) :132-140
[9]  
Hohenegger M, 1996, MOL PHARMACOL, V50, P1443
[10]   Lys515-Lys492 cross-linking by DIDS interferes with substrate utilization by the sarcoplasmic reticulum ATPase [J].
Hua, SM ;
Inesi, G .
BIOPHYSICAL JOURNAL, 1997, 73 (04) :2149-2155